Filtrer vos résultats
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailtyBMC Geriatrics, 2016, 16 (1), pp.187. ⟨10.1186/s12877-016-0360-9⟩
Article dans une revue
hal-01444161v1
|
||
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III TrialJournal of Clinical Oncology, 2018, 36 (15), pp.1469-1477. ⟨10.1200/JCO.2017.76.0355⟩
Article dans une revue
hal-01951156v1
|